Biopharmaceutical company developing precision therapies for cardiac arrhythmias, including arrhythmogenic right ventricular cardiomyopathy (ARVC), cardiac sarcoidosis, and post-COVID arrhythmias
Biopharmaceutical company developing precision therapies for cardiac arrhythmias, including arrhythmogenic right ventricular cardiomyopathy (ARVC), cardiac sarcoidosis, and post-COVID arrhythmias. Its approach combines cardiac biology, immune biology, and precision medicine.